FDA to Issue New Commissioner’s National Priority Vouchers to Companies Supporting U.S. National Interests

The U.S. Food and Drug Administration today announced its Commissioner’s National Priority Voucher (CNPV) program to enhance the health interests of Americans. The new voucher may be redeemed by drug

RECALLS, MARKET WITHDRAWALS, & SAFETY ALERTS

Alerting you to the latest recalls of potentially unsafe FDA-regulated products gathered from press releases and other public notices. Not all recalls have press releases or are posted on this website.

FDA VOICES: PERSPECTIVES FROM FDA EXPERTS

CDER Brings Many Safe and Effective Therapies to Patients and Consumers in 2024

By: Patrizia Cavazzoni, M.D., Director, Center for Drug Research and Evaluation Each year, the U.S.

Youth Tobacco Product Use Continues to Decline as FDA Actions Build Momentum

By: Dr. Brian King, Director of FDA’s Center for Tobacco Products As Director of the

Upholding Public Trust: FDA Office of Criminal Investigations’ Crucial Role in Bringing Drug Criminals to Justice

By: Justin D. Green, MBA, MDiv., Assistant Commissioner, FDA Office of Criminal Investigations A few

View More FDA Voices